Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations may diminish
vaccine-induced protective immune responses, particularly as antibody titers wane over time. …

Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …

Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …

As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have
been reported from 35 countries, including the USA 1 , 2 . Previous studies have found …

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …

OBJECTIVES: We aimed to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serological responses in children hospitalized with multisystem inflammatory …

Low plasma arginine bioavailability has been implicated in endothelial dysfunction and
immune dysregulation. The role of arginine in COVID-19 is unknown, but could contribute to …

Children could benefit both directly and indirectly from vaccination. In light of the safety and
immunogenicity results from recent adult COVID-19 vaccine clinical trials, children should …

Background: Distinguishing multisystem inflammatory syndrome in children (MIS-C) from
coronavirus disease 2019 (COVID-19), Kawasaki disease (KD), and toxic shock syndrome (TSS…

The pathogenesis of multi-organ dysfunction associated with severe acute SARS-CoV-2
infection remains poorly understood. Endothelial damage and microvascular thrombosis have …